Virus-like particle size and molecular weight/mass determination applying gas-phase electrophoresis (native nES GEMMA) by Weiss, Victor U. et al.
PAPER IN FOREFRONT
Virus-like particle size and molecular weight/mass determination
applying gas-phase electrophoresis (native nES GEMMA)
Victor U. Weiss1 & Ronja Pogan2,3 & Samuele Zoratto1 & Kevin M. Bond4 & Pascale Boulanger5 & Martin F. Jarrold4 &
Nicholas Lyktey4 & Dominik Pahl6 & Nicole Puffler1 & Mario Schelhaas6 & Ekaterina Selivanovitch4 &
Charlotte Uetrecht2,3 & Günter Allmaier1
Received: 16 April 2019 /Revised: 29 May 2019 /Accepted: 24 June 2019 /Published online: 6 July 2019
# The Author(s) 2019
Abstract
(Bio-)nanoparticle analysis employing a nano-electrospray gas-phase electrophoretic mobility molecular analyzer (native nES
GEMMA) also known as nES differential mobility analyzer (nES DMA) is based on surface-dry analyte separation at ambient
pressure. Based on electrophoretic principles, single-charged nanoparticles are separated according to their electrophoretic
mobility diameter (EMD) corresponding to the particle size for spherical analytes. Subsequently, it is possible to correlate the
(bio-)nanoparticle EMDs to their molecular weight (MW) yielding a corresponding fitted curve for an investigated analyte class.
Based on such a correlation, (bio-)nanoparticle MW determination via its EMD within one analyte class is possible. Turning our
attention to icosahedral, non-enveloped virus-like particles (VLPs), proteinaceous shells, we set up an EMD/MW correlation. We
employed native electrospray ionization mass spectrometry (native ESIMS) to obtain MW values of investigated analytes, where
possible, after extensive purification. We experienced difficulties in native ESI MS with time-of-flight (ToF) detection to
determine MW due to sample inherent characteristics, which was not the case for charge detection (CDMS). nES GEMMA
exceeds CDMS in speed of analysis and is likewise less dependent on sample purity and homogeneity. Hence, gas-phase
electrophoresis yields calculated MW values in good approximation even when charge resolution was not obtained in native
ESI ToF MS. Therefore, both methods-native nES GEMMA-based MW determination via an analyte class inherent EMD/MW
correlation and native ESI MS-in the end relate (bio-)nanoparticle MW values. However, they differ significantly in, e.g., ease of
instrument operation, sample and analyte handling, or costs of instrumentation.
Keywords Native nESGEMMA .DMA .VLP .Molecular weight/mass . Size . Mass spectrometry
Victor U. Weiss and Ronja Pogan contributed equally to this work.
Electronic supplementary material The online version of this article
(https://doi.org/10.1007/s00216-019-01998-6) contains supplementary
material, which is available to authorized users.
* Victor U. Weiss
victor.weiss@tuwien.ac.at
1 Institute of Chemical Technologies and Analytics, TU Wien,
Getreidemarkt 9/164, 1060 Vienna, Austria
2 Heinrich Pette Institute, Leibniz Institute for Experimental Virology,
Martinistraße 52, 20251 Hamburg, Germany
3 European XFEL GmbH, Holzkoppel 4, 22869 Schenefeld, Germany
4 Department of Chemistry, Indiana University, 800 E Kirkwood Ave,
Bloomington, IN 47405, USA
5 Institute for Integrative Biology of the Cell, CEA, CNRS, Université
Paris-Sud, Université Paris-Saclay, 91198 Gif-sur-Yvette, France
6 Institute of Cellular Virology, WWU Münster, Von-Esmarch-Str. 56,
48149 Münster, Germany
Analytical and Bioanalytical Chemistry (2019) 411:5951–5962
https://doi.org/10.1007/s00216-019-01998-6
Introduction
Viruses are nanoparticles of biological origin: A proteinaceous
capsid protects the viral genome from the exterior. Additional
protection can be conveyed by a lipid membrane, which is
additionally modified by (glyco-) proteins to enable attach-
ment to target cells (e.g., [1]). Only upon target cell infection,
the genomic material of the virus is intended for release. This
concept is of interest for pharmacological applications as virus
bionanoparticles can be interpreted as carriers enabling the
shielded, targeted transport of cargo material. Alternatively,
viral particles without any encapsulated cargo can be
employed for vaccination. In both cases, corresponding parti-
cles are referred to as virus-like particles (VLPs) (e.g., [2]).
To allow for VLP application in the field of pharmaceutics,
their thorough characterization and preparation batch control,
e.g., in terms of particle homogeneity, purity of preparations,
particle size, and molecular weight (MW), is of importance.
For the latter, native electrospray ionization mass spectrome-
try (native ESI MS) mostly in combination with time-of-flight
(ToF) analyzers evolved as method of choice, yielding MW
values of bionanoparticles after deconvolution of mass spec-
tra. Such, the MWof dimorphic hepatitis B-based VLPs could
be obtained already in 2008 [3]. In addition, several other
VLPs or subviral particles [4, 5] up to a maximum MW of
17.9 MDa with charge state assignment [6] or employing
cryodetection with matrix assisted laser desorption/ionization
time-of-flight (MALDI TOF) MS [7] could be investigated.
ESI with charge detection mass spectrometry (CDMS) [8, 9]
even allowed detection of VLPs up to 26.8 MDa, employing
bacteriophage P22 as model [10, 11]. Besides enabling the
analysis of VLPs, also capsid binding to antibody fragments
[12], pH-dependent VLP decomposition [13] or the investiga-
tion of VLP capsid assembly [14] was accessible via native
ESIMS. However, none of these measurements can be carried
out on standard commercial instruments. Employed mass
spectrometers are usually customized in terms of, e.g., applied
pressures, employed carrier gas or voltage settings, or pose
completely new instrumental developments. In 2018, for in-
stance, Dominguez-Medina and coworkers reported the anal-
ysis of bacteriophage T5 icosahedral capsids either in their
empty VLP form (MW ~ 27 MDa) or in their DNA-filled
native form (MW ~ 108 MDa) [15]. For these experiments,
nanochemical resonators were employed [16, 17].
As alternative, MW determination can also be based on gas-
phase electrophoresis data employing a nano-electrospray
gas-phase electrophoretic mobility molecular analyzer (native
nES GEMMA also known as nES differential mobility ana-
lyzer, nES DMA) [18]. Bionanoparticles are electrosprayed
from a volatile, aqueous electrolyte solution. Subsequently,
droplets are dried. At the same time, charge equilibration oc-
curs in a bipolar atmosphere induced by, e.g., an α-particle
emitter like 210Po, an alternating corona discharger or a soft X-
ray tube [19, 20]. Hence, singly charged particles are obtained
(besides a majority of neutral objects), which are then separat-
ed according to electrophoretic principles in the gas phase at
ambient pressure. A particle charge of one leads to
bionanoparticle separation according only to the surface-dry
particle size (electrophoretic mobility diameter, EMD) in a
high laminar sheath flow of particle-free, dried air, and a tun-
able electric field. Variation of the field strength enables size
separation of sample components. The obtainedmonodisperse
aerosol is subsequently introduced to the detector unit of the
instrument (ultrafine condensation particle counter, CPC),
where bionanoparticles act as condensation nuclei in a super-
saturated atmosphere of either n-butanol or water. Obtained
droplets are counted as they pass a focused laser beam. Such
an instrumentation has previously been employed for the anal-
ysis of liposomes [21, 22], exosomes [23], viruses [24–29],
proteins and protein aggregates [30], polysaccharides
[31–33], DNA [34], polymers [35–37], and nanoparticles in
general [38–42]. Besides yielding information on analyte
surface-dry particle size and size distribution, particle number
concentration detection is possible in accordance with recom-
mendations of the European Commission for characterization
of nanoparticle material (2011/696/EU from October 18th,
2011). Furthermore, analytes can be size-selected for further
analyses employing orthogonal methods for instance electron
microscopy [43], atomic force microscopy [44], spectroscopic
techniques [45, 46], or antibody-based nanoparticle recogni-
tion [44, 47]. It is of note that LiquiScan ES, MacroIMS, and
SMPS are synonyms of the same instrument found in
literature.
Furthermore, as first demonstrated in great detail by Bacher
and colleagues [48] for proteins, obtained EMD results can be
related to particle MW values yielding a corresponding corre-
lation. Hence, based on a protein EMD value, its MW can be
calculated in good approximation. Similar approaches have
been demonstrated, e.g., for intact viruses [4] and polysaccha-
rides [32]. It is of note that for the latter two, the obtained
EMD/MW correlations deviated from the protein case. For
instance for polysaccharides, it was reasoned that additional
factors might influence the EMD/MW correlation, inter alia
particle shape, or insufficient characterization of applied, com-
mercially available standards. Likewise, for elongated virus
structures (tobacco mosaic virus), effects like bending of
analytes due to surface effects of droplets generated during
the nES process were observed [49].
In the current manuscript, we focus on nano-objects, name-
ly VLPs, which are approximately spherical (icosahedral) and
non-enveloped (empty protein shells). We asked ourselves, if
a native nES GEMMA-based EMD/MW correlation for VLPs
is likewise differing from correlations described for other clas-
ses of analytes. In addition, we wanted to investigate if a
corresponding EMD/MW correlation will allow an approx.
MW determination of this class of bionanoparticles with a
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relatively quick, cheap (~ 80.000 €), less challenging (in terms
of sample quality) and easy to handle analytical setup in com-
parison to native ESI MS. Mind however, that a high accuracy
MW determination of VLPs is only possible on the basis of
MS-derived data. Hence, both methods have to be regarded as
yielding complementary information in terms of analyte size
and MW, sample quality, and particle number concentration.
Materials and methods
Chemicals Ammonium acetate (NH4OAc, ≥ 99.99%) and am-
monium hydroxide (ACS reagent) were both purchased from
Sigma-Aldrich (Steinheim, Germany).
Electrolyte NH4OAc, 40 mM ammonium acetate at pH 7.0
was used as electrolyte solution for desalting of VLPs and
for sample dilution for nES GEMMA and ESI MS.
Electrolyte solutions for CDMS measurements are detailed
with corresponding experiments. NH4OAc solution was fil-
tered (0.2 μm pore size syringe filters, Sartorius, Göttingen,
Germany) prior application. Millipore (Billerica, MA, USA)
grade water was employed (18.2 MΩcm resistivity at 25 °C).
Biological materialNorovirus West Chester GI.1 VLPs (3 mg/
mL in PBS, pH 7.4) were produced in insect cells and kindly
provided by Grant Hansman, Heidelberg, Germany, and
CPMV VLPs (4 mg/mL in 10 mM sodium phosphate,
pH 7.0) were from John Innes Centre (kindly provided by
George Lomonossoff, Norwich, UK). Bacteriophage P22
VLPs (2 mg/mL in 50 mM sodium phosphate, pH 7.0 includ-
ing 100 mM sodium chloride and 200 ppm sodium azide)
were obtained from Indiana University Bloomington
(Bloomington, IN, USA), bacteriophage T5 VLPs (0.3 mg/
mL, i.e., 7 × 1012 empty capsids/mL in PBS) from the
Institute for Integrative Biology of the Cell (I2BC), Gif-sur-
Yvette, France). Human papillomavirus type 16 (HPV16,
0.3 mg/mL in PBS additionally including 625 mM sodium
chloride, 0.9 mM calcium chloride, 0.5 mMmagnesium chlo-
ride, and 2.1 mM potassium chloride) VLPs were prepared
from mammalian cells as previously described [50].
InstrumentationGas-phase electrophoresis was performed on
two setups: a nES GEMMA instrument (TSI Inc., Shoreview,
MN, USA) consisting of a nES aerosol generator (model
3480) including a 210Po α-particle source, an electrostatic
classifier (model 3080) with a nano-differential mobility ana-
lyzer (nDMA) and an n-butanol-based ultrafine condensation
particle counter (model 3025A or 3776C) was applied as in-
strument A. Instrument B consisted of a model 3482 nES
aerosol generator including a soft X-ray source, an electrostat-
ic classifier (model 3082) and a water-based ultrafine conden-
sation particle counter (model 3788). Twenty-five µm inner
diameter polyimide coated fused silica capillaries (Polymicro,
obtained via Optronis, Kehl, Germany) with in-house made
tips [51] were employed to transfer analytes from the liquid to
the gas phase. Settings for a stable Taylor cone at the nES tip
were chosen, typically around 2 kV voltage resulting in
approx. − 375 nA current, 0.1 liters per minute (Lpm) CO2
(Messer, Gumpoldskirchen, Austria) and 1.0 Lpm filtered,
dried ambient air. Four pounds per square inch differential
(psid, approx. 27.6 kPa) were applied to additionally move
the sample through the capillary. Fifteen Lpm sheath flow
filtered ambient air was used to size-separate VLPs in an
EMD range from 2 to 65 nm. The corresponding EMD size
range was scanned for 120 s. Subsequently, the applied volt-
age was adjusted to starting values within a 30-s timeframe.
Seven datasets (raw data obtained from instrument software,
MacroIMS manager v2.0.1.0) were combined via their medi-
an to yield a corresponding spectrum. Lastly, Gaussian peaks
were fitted to spectra via Origin software (OriginPro v9.1.0) to
obtain EMD values.
HPV16 VLPs cannot be produced in high yields. Due to
the resulting low VLP concentration, samples were only ana-
lyzed between 30 and 65 nm EMD to increase the scanning
time in this range. In addition, a 40 μm inner diameter capil-
lary was employed to reduce the surface to volume ratio and
hence the probability of analyte loss due to VLP interaction
with the fused silica material of the nES capillary. This result-
ed in significantly higher particle numbers detected per chan-
nel and hence a discernible VLP peak.
For CPMV and P22 VLPs, native MS was performed
on a Q-Tof 2 instrument (Waters, Manchester, UK, and
MS Vision, Almere, the Netherlands) modified for high
mass experiments [52, 53] and calibrated with cesium
iodide. A nano-ESI source in positive ion mode with a
source pressure of 10 mbar was used. Capillaries were
produced in-house. Borosilicate glass tubes (inner diame-
ter 0.68 mm, outer diameter 1.2 mm with filament; World
Precision Instruments, Sarasota, FL, USA) were pulled
using a two-step program in a micropipette puller (model
P-1000 from Sutter Instruments, Novato, CA, USA) with
a squared box filament (2.5 × 2.5 mm). Subsequently, the
capillaries were gold-coated using a sputter coater
(Quorum Technologies, East Sussex, UK, 40 mA, 200 s,
tooling factor of 2.3 and end bleed vacuum of 8 ×
10−2 mbar argon) and opened directly on the sample cone
of the mass spectrometer. Voltages of 1.45–1.65 kV and
145–155 V were applied to the capillary and cone, respec-
tively. Xenon (purity 5.0) was used as collision gas at a
pressure of 1.7–2.0 × 10−2 mbar to improve the transmis-
sion of large ions [53]. Collision energies were ramped
from 10 to 400 V. MS profile and repetition frequency
of the pusher pulse were adjusted to high mass range.
Mass spectra were analyzed using MassLynx (Waters,
Manchester, UK).
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Mass spectra of norovirus West Chester VLPs were obtain-
ed using a home-built ESI CDMS system, described in detail
elsewhere [54]. Briefly, CDMS is a single particle MS tech-
nique, which retrieves m/z and z for each ion allowing direct
mass determination from a charge conducting cylinder func-
tioning also as electrostatic ion trap. Hence, masses of large,
heterogeneous biological complexes can be measured. An au-
tomated nano-ESI source (Advion, Ithaca, NY, USA) was
used to generate ions with a capillary voltage of 1.7 kV. The
ions then enter a heated metal capillary and are transmitted
using various ion optics to a dual hemispherical deflection
energy analyzer which selects ions with energies centered on
100 eV/z. These ions then enter a modified cone trap. Here,
trapped ions oscillate back and forth in a charge detection
cylinder for 100 ms. Mass spectra were generated by binning
of the single ion masses. Spectra were subsequently analyzed
by fitting Gaussian peaks with Origin software (OriginPro
2016).
Sample preparation In order to enable native nES-based anal-
ysis of VLPs, employed storage buffers (often including ad-
ditional salt components or stabilizing agents) had to be re-
placed by a volatile electrolyte solution. Else, these additional
sample components were shown to lead to an increased peak
heterogeneity of the analytes of interest and, in nESGEMMA,
an elevated baseline resulting from clustering of small, non-
volatile molecules during the nES process [55]. As in previous
studies, we opted for ammonium acetate and carried out re-
moval of small, buffer-associated sample components via spin
filtration [42] employing 10 kDa MW cutoff filters (Vivaspin-
polyethersulfone membrane, Vivacon-regenerated cellulose
membrane-both from Sartorius or centrifugal filters-
polyethersulfone membrane, VWR, Vienna, Austria).
Between 3 and 5 filtration steps were necessary to remove
non-volatile additional sample components. Sample concen-
tration for measurements was typically well below 1 mg/mL
protein content (based on originally determined values and
sample dilution).
Results and discussion
It was the aim of our investigation to analyze VLP material
with gas-phase electrophoresis on a native nES GEMMA in-
strument and to compare results with data obtained from na-
tive ESI MS and from literature. We intended to setup an
EMD/MW correlation for VLPs to allow for future VLP MW
determination based on gas-phase electrophoresis directed to-
wards analysis of samples not applicable to native ESI ToF
MS.
Native nES GEMMA analysis of VLPs In previous work, we had
already described the analysis of VLP or VLP-like material
based on hepatitis B virus capsids (HBV) with two icosahe-
dral symmetries [12] and subviral particles of a human rhino-
virus serotype (HRV-A2) [4]. We now turned to further VLP
material and analyzed bionanoparticles derived from cowpea
mosaic virus (CPMV), a norovirus strain and particles from
bacteriophage P22 and T5 via gas-phase electrophoresis.
Figure 1 depicts corresponding native nES GEMMA spectra.
An overview of investigated VLPs and resulting EMD values
are listed in Table 1. In order to exclude the possibility of
unspecific aggregation of sample components, VLPs were
electrosprayed from samples diluted to at least three different
concentrations. Unspecific aggregation of components was
excluded, if peaks remained at identical EMD values for all
investigated dilutions.
Besides information on the surface-dry VLP size and an
approximation on the bionanoparticle number concentration,
two other pieces of information could be gathered from native
nES GEMMA spectra. (i) Especially for norovirus West
Chester VLPs (Fig. 1b), detection of material below 10 nm
EMD hinted the presence of free proteins. Pogan et al. [13]
showed that these particles already disassemble at neutral pH
and low ionic strengths, which is in line with our results.
Moreover, general particle rupture in the nES process is un-
likely, as such peaks were only recorded for norovirus West
Chester VLPs. (ii) Especially for bacteriophage P22-based
VLPs (Fig. 1c) several additional species with significantly
lower abundance than the main VLP peak were detected
(e.g., at 34 or 45 nm EMD). If these peaks correspond to
species simply carrying a higher number of charges from in-
sufficient charge equilibration in the bipolar atmosphere of the
nES unit or are analytes of biological relevance (e.g., capsids
losing subunits) cannot be determined based on obtained na-
tive nES GEMMA results alone. However, ESI ToF MS also
showed at least one additional species, which indicates that the
observed peaks correspond to different assemblies present in
solution (Fig. 2).
Native ESI MS analysis of VLPs Next to targeting these VLP
analytes via native nES GEMMA, we also applied native ESI
MS in VLP characterization. Employing Q-ToF instruments,
challenges of VLP MW determination in native ESI MS be-
come obvious. For the same samples as with native nES
GEMMA, clear peaks were obtained via native ESI ToF MS
(Fig. 2). However, the lack of charge state separation ham-
pered exact mass determination. Common sources for lack of
resolution are intrinsic VLP heterogeneity mostly on protein
level, e.g., the presence of truncated protein or sequence var-
iants, or simply size resulting in overlapping charge states. As
was shown in a previous study, the problems in charge state
resolution can be instrument, but as well analyte derived [3].
Furthermore, incomplete desolvation can additionally cause
peak broadening, which influences native ESI ToF MS to a
higher extent than gas-phase electrophoresis. Nevertheless,
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using an experimentally derived equation [57], also in such
cases, the MW can be estimated from the obtained m/z values.
Taking for instance m/z of 22,600 for CPMV into consider-
ation, a MW of 3107 kDa is obtained, for bacteriophage P22,
anm/z of 55,600 yields a MWof 18,807 kDa. Both MW values
are in the same range as data found in literature (see Table 1).
In general, the spectra show that the number of different ob-
served sizes is in line with the nES GEMMA results.
Moreover, the norovirus VLPs were also analyzed on an ESI
CDMS instrument to provide MW values without the need for
charge state resolution and obtain more values for the corre-
lation (Electronic Supplementary Material (ESM) Fig. S1).
Additionally, application of an Orbitrap instrument with
higher resolution might help to resolve charge states in a fu-
ture study.
Combining native nES GEMMA and native ESI MS data yields
an EMD/MW correlation for VLPs Based on our analyses of
VLP material via native nES GEMMA and accurate mass
values from native ESI MS including literature values (given
in Table 1), we set up a corresponding EMD/MW correlation:
y [MW in kDa] = 0.7601 [EMD in nm]
2.6319 (Fig. 3). Notably,
this deviates from a correlation for proteins as was the case for
filled virions [32]. Hence, a basic knowledge concerning the
analyte class prior EMD-based MW calculation (but not for
gas-phase electrophoresis itself) is necessary.
Fig. 1 nES GEMMA data for
VLPs: CPMV (a), norovirusWest
Chester (b), bacteriophage P22
(c), and bacteriophage T5 capsids
(d). All VLPs are shown in three
different dilutions of obtained
material after solution exchange
to 40 mM NH4OAc, pH 7.0
employing 10 kDa MW cutoff
membrane filters. (Typically,
overall dilutions were in the range
of 1:10 to 1:250 [v:v] of the
original VLP stock solutions
resulting from solution exchange
and sample dilution steps)
Table 1 Overview on investigated VLP material as well as data taken from literature as indicated
VLP EM diameter (nm) Based on MW (kDa) Based on
1 Norovirus West Chester T1 VLP 24.22 ± 0.21 – 3320 ± 30 CDMS
2 Hepatitis B virus (HBV) T3 VLP 24.22 ± 0.40 [12] 3004 ± 3 MS [12]
3 Hepatitis B virus (HBV) T4 VLP 26.84 ± 0.44 [12] 4006 ± 3 MS [12]
4 Cowpea mosaic virus (CPMV) VLP 27.88 ± 0.04 – 3940 ± n.a. [56]
5 Subviral B particle of human rhinovirus 2 28.68 ± 0.07 [4] 5210 ± 2 MS [4]
6 Norovirus West Chester T3 VLP 34.47 ± 0.15 – 10,260 ± 40 CDMS
7 Bacteriophage P22 VLP 48.44 ± 0.12 – 19,840 ± n.a. MS [11]
8 Bacteriophage T5 VLP 53.45 ± 0.09 – 27,200 ± 2300 MS [15]
New data is presented in italics. An exemplary CDMS spectrum of investigated VLPs is shown in the ESM (Fig. S1). At least N = 3 technical replicates
were used per EMD value. Errors provided are standard deviations
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A collapse of VLP particles during gas-phase electropho-
resis upon stripping of solvent molecules from their interior
seems highly unlikely as AFM and dot-blot analyses of a
vaccine VLP demonstrated particle integrity after gas-phase
electrophoresis [44]. Instead, due to protein analyte inherent
MW limitations, especially a direct comparison of a protein
correlation with an EMD/MW correlation for VLPs is to date
not feasible. Simply because VLPs are analyzed in an EMD/
MW range, in which pure protein complexes (in a non-
aggregated or structured form) rarely exist, the extrapolation
of the protein EMD/MW correlation to larger EMD and MW
values has to be taken with extreme caution. It is of note that
the largest protein analyzed in [32] was the octamer of β-
galactosidase with an EMD of 16.83 nm and a MW of
931.28 kDa.
In contrast, the VLP-based EMD/MW correlation is based
on data points for larger EMD/MW values. VLPs with low
EMD/MW value are not reasonable as the proteinaceous
sphere has to be of a certain lower size limit (around 20 nm)
in order to allow for genome encapsulation within the capsid.
Therefore, there is poor overlap between pure protein complex
andVLP curves. Extrapolation of either the protein correlation
to large or the VLP correlation to lower EMD/MW values is
problematic. Hence, we advise against taking one single
EMD/MW correlation for all investigated analyte classes in
order to calculate MW values based on a particle EMD.
EMD/MW correlations on different native nES GEMMA instru-
ments As it was our intention to setup an EMD/MW correla-
tion for VLPs applicable to as many as possible corresponding
native nES GEMMA instrumentations, we asked ourselves, if
obtained results can be ported between setups. Laschober and
colleagues already reported in 2007 differences of up to 15%
in obtained EMD values for globular proteins up to 660 kDa
[58]. Especially slight variations in nDMA geometries, length
values of connecting tubes between instrument parts or differ-
ences in sheath flow values may lead to deviations observed
between instruments. Therefore, we analyzed a set of analytes
on another gas-phase electrophoretic setup besides our stan-
dard native nES GEMMA (instrument A). This instrument
corresponded to a next-generation setup with differences in
the geometry of the nES source and a soft X-ray source for
charge equilibration (instrument B). Detection on the latter
instrumentation was carried out on a water-based CPC. We
Fig. 2 QTOF native ESI MS data for VLPs: CPMV at 50 V collision
energy (a) and bacteriophage P22 at 100 V collision energy (b) are
shown. Although in both cases signals are detected, analyte
heterogeneity precluded charge state resolution. m/z values at peak
apices are given. VLPs were exchanged to 40 mM NH4OAc, pH 7.0,
using 10 kDa MW cutoff filters. Peaks at 14,000, 27,000, and 32,000 m/z
may represent metastable ions
Fig. 4 Comparing gas-phase electrophoresis data obtained on two instru-
ment generations. As shown for bacteriophage P22, a significant shift in
obtained EMD values on both instruments is found. Corresponding EMD
data is found in Table 2
Fig. 3 nES GEMMA and MS data can be related to yield an EMD/MW
correlation valid for VLPs. The numbering of data points correlates to
Table 1
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opted for immunoglobulin G (IgG), β-galactosidase (β-Gal),
several polysaccharides (dextrans and oat β glucans), CPMV
VLP, and bacteriophage P22 VLP as analytes.
Resulting spectra from gas-phase electrophoresis carried out
on the two instrumentations are depicted in Fig. 4 as exemplified
by P22 VLPs. Corresponding data for all analytes is given in
Table 2. As can be seen, indeed slight differences between in-
strumentations were detected. For instance, the EMD of investi-
gated proteins deviated on average by 4.5% at the peak apex
between our standard instrumentation (instrument A) and the
next-generation setup (instrument B). Less variation was found
for VLPs, more for polysaccharides. Based on this data, we
strongly suggest calibration of each instrument for corresponding
EMD-based MW calculation: Instrument specific parameters
have to be regarded in order to obtain reliable EMD-based MW
values via gas-phase electrophoresis. A simple porting of EMD/
MW correlations between instrumentations without considering a
corresponding deviation would lead to significant systematic er-
rors in EMD-based particle MW calculation.
Application of the developed EMD/MW correlation in VLP re-
search, an example Following the setup of our EMD/MW
correlation for VLPs, we turned to another VLP based on
HPV16, for which no native MS data was obtained so far.
We carried out our analyses on our standard instrumentation
(instrument A). Employing native nES GEMMA, we could
obtain a peak at 47.78 ± 0.29 nm EM diameter (N = 4 mea-
surements, Fig. 5). Subsequently, we employed our EMD/MW
correlation for the calculation of the VLP MW. A result of
19,975 kDa is in good accordance with the expected value
of 20,260 kDa (based on 72 pentamers of coat protein L1,
Uniprot data, P03101, retrieved on January 17th, 2019); the
deviation is in fact below 1.5%. Reasons for this deviation
could be inter alia (i) a still relatively low number of data
points available for the VLP EMD/MW correlation, (ii) the
shape, surface texture, or tightness of the proteinaceous shell
itself, (iii) additional material encapsulated within VLPs, or
(iv) differences between VLP material measured via native
nES GEMMA and material described in the database.
Nevertheless, employing HPV16 as an exemplary VLP
bionanoparticle, we were able to demonstrate the applicability
of native nES GEMMA-based MW determination of VLP
analytes.
Concluding remarks
For pharmaceutical applications as pointed out above, the
thorough characterization of VLPs in terms of particle size,
Table 2 Comparison of averaged













IgG M 147.27 9.03 0.10 95.19 9.49 0.04
IgG D 294.54 11.26 0.10 95.58 11.78 0.04
β-Gal M 116.41 8.33 0.11 95.76 8.70 0.03
β-Gal D 232.82 10.57 0.11 95.52 11.07 0.02
Dextran 150 M 147.6 8.17 0.15 98.67 8.28 0.01
Dextran 670 M 667.8 10.05 0.41 92.88 10.82 0.12
Oat β glucan 80 M 81 7.12 0.04 93.81 7.59 0.03
Oat β glucan
1500
M 1508 7.71 0.15 94.83 8.13 0.04
CPMV VLP M 3940 27.88 0.04 99.32 28.07 0.07
P22 VLP M 19,840 48.44 0.12 97.21 49.83 0.07
At least N = 3 measurements were considered per EMD value. MW values and data for instrument A either taken
from [32] or Table 1. M monomer, D dimer; errors provided are standard deviations
Fig. 5 nES GEMMAyields a peak for HPV16-based VLPs allowing its
subsequent MW determination based on the correlation presented in Fig.
3. The calculated MW (19,975 kDa) is in good accordance with the the-
oretically expected MW value (20,260 kDa, based on VLP stoichiometry
and database MW values for individual viral proteins)
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MW, sample, and analyte heterogeneity and particle number-
based concentration is a necessary prerequisite. In general, it
can be seen that ESI MS, whether from ToF or CDMS instru-
ments, is in good agreement with nES GEMMA in terms of
species detected. Hence, ESI MS results can be used to inter-
pret nES GEMMA data of unknown samples. However, al-
though native ESI ToF MS is unrivaled in VLP MW determi-
nation, it often experiences problems due to sample specific
problems, like heterogeneity or low particle numbers. Even
though ESI CDMS is not suffering from sample heterogeneity,
it is slow, requiring several hours per mass spectrum, and the
home-built instrumentation is not widely accessible. nES
GEMMA on the other hand is less prone to the mentioned
sample inherent characteristics and is relatively cheap facili-
tating wide application. Analytes are separated according to
electrophoretic principles in the gas-phase at ambient pressure
based on their size yielding particle number-based concentra-
tions. As has already been shown for other analyte classes, a
subsequent correlation between the nES GEMMA-derived
EMD and the particle MW allows (bio-)nanoparticle MW cal-
culation in good approximation. We now focused on spherical
VLPs and analyzed a variety of these bionanoparticles to setup
an EMD/MW correlation, which we found significantly differ-
ent from correlations known for, e.g., proteins or intact virus
particles. As such, it is crucial to know the nature of samples
prior to MW determination. As demonstrated, application of
this correlation allowed us to calculate the MW of a VLP, for
which native ESI MS data is not available to date. Especially
through the combination of both methods, nES GEMMA and
native ESI MS, as exemplified here, a thorough VLP charac-
terization will be feasible in the future.
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